Bonecchi R, Mantovani A, Jaillon S. Chemokines as Regulators of Neutrophils: Focus on Tumors, Therapeutic Targeting, and Immunotherapy. Cancers (Basel). 2022 Jan 28;14(3):680. doi: 10.3390/cancers14030680. PMID: 35158948.
Simonelli M, Persico P, Capucetti A, Carenza C, Franzese S, Lorenzi E, Dipasquale A, Losurdo A, Giordano L, Pessina F, Navarria P, Politi LS, Mavilio D, Locati M, Della Bella S, Santoro A, Bonecchi R. Immunotherapeutic early-phase clinical trials and malignant gliomas: A single-center experience and comprehensive immunophenotyping of circulating leukocytes. Neurooncol Adv. 2021 Nov 13;3(1):vdab160. doi: 10.1093/noajnl/vdab160. PMID: 34901858
Capucetti A, Albano F, Bonecchi R. Multiple Roles for Chemokines in Neutrophil Biology. Front Immunol. 2020 Jul 9; 11:1259. doi:10.3389/fimmu.2020.01259. PMID: 32733442; PMCID: PMC7363767
Jaillon S, Ponzetta A, Di Mitri D, Santoni A, Bonecchi R, Mantovani A. Neutrophil diversity and plasticity in tumour progression and therapy. Nat Rev Cancer. 2020 Sep;20(9):485-503. doi: 10.1038/s41568-020-0281-
Borroni EM, Savino B, Bonecchi R, Locati M. Chemokines sound the alarmin: The role of atypical chemokine receptors in inflammation and cancer. Semin Immunol. 2019 Apr;42:101268. doi: 10.1016/j.smim.2019.02.002.
Mantovani A, Bonecchi R. One Clever Macrophage Checkpoint. Clin Cancer Res. 2019 Jun 1;25(11):3202-3204. doi: 10.1158/1078-0432.CCR-19-0483.
Mollica Poeta V, Massara M, Capucetti A, Bonecchi R. Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy. Front Immunol. 2019 Mar 6;10:379. doi: 10.3389/fimmu.2019.00379.
Massara M, Bonavita O, Savino B, Caronni N, Mollica Poeta V, Sironi M, Setten E, Recordati C, Crisafulli L, Ficara F, Mantovani A, Locati M, Bonecchi R. ACKR2 in hematopoietic precursors as a checkpoint of neutrophil release and anti-metastatic activity. Nat Commun. 2018 Feb 14;9(1):676. doi:10.1038/s41467-018-03080-8.
Locati M, Mantovani A, Bonecchi R. Atypical matters in myeloid differentiation. Nat Immunol. 2017 Jun 20;18(7):711-712. doi: 10.1038/ni.3776.
Savino B, Caronni N, Anselmo A, Pasqualini F, Borroni EM, Basso G, Celesti G, Laghi L, Tourlaki A, Boneschi V, Brambilla L, Nebuloni M, Vago G, Mantovani A, Locati M, Bonecchi R. ERK-dependent downregulation of the atypical chemokine receptor D6 drives tumor aggressiveness in Kaposi sarcoma. Cancer Immunol Res. 2014 Jul;2(7):679-89. doi: 10.1158/2326-6066.CIR-13-0202.